Italian consumption of plasma-derived factor VIII after the SIPPET study

被引：1
|
作者：
Traversa, Giuseppe [1 ]
Trotta, Francesco [2 ]
机构：
[1] Natl Inst Hlth, Natl Ctr Epidemiol, Pharmacoepidemiol Unit, Rome, Italy
[2] Lazio Reg Hlth Serv, Dept Epidemiol, Via Cristoforo Colombo 112, I-00147 Rome, Italy
来源：
BLOOD TRANSFUSION | 2017年 / 15卷 / 03期
关键词：
HEMOPHILIA-A; UPDATE;
D O I：
10.2450/2017.0035-17
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：283 / 284
页数：2
相关论文
共 50 条
  • [1] Timing and severity of inhibitor development in recombinant versus plasma-derived factor VIII concentrates: a SIPPET analysis
    Peyvandi, F.
    Cannavo, A.
    Garagiola, I.
    Palla, R.
    Mannucci, P. M.
    Rosendaal, F. R.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2018, 16 (01) : 39 - 43
  • [2] Why plasma-derived factor VIII?
    Aledort, Louis
    Carpenter, Shannon L.
    Cuker, Adam
    Kulkarni, Roshni
    Recht, Michael
    Young, Guy
    Leissinger, Cindy
    HAEMOPHILIA, 2019, 25 (03) : E183 - E185
  • [3] Lower inhibitor risk of plasma-derived factor VIII concentrates versus recombinant factor VIII concentrates in patients with severe haemophilia A : result from SIPPET study and comments
    Biron-Andreani, Christine
    Diaz, Isabelle
    Navarro, Robert
    Schved, Jean-Francois
    HEMATOLOGIE, 2019, 25 (02): : 93 - 99
  • [4] The ethical concern about using plasma-derived factor VIII concentrates in the US for the SIPPET study: What is the current safety profile of Alphanate®?
    Kruse-Jarres, Rebecca
    Mathew, Prasad
    Tarantino, Michael
    Valentino, Leonard
    HAEMOPHILIA, 2011, 17 (03) : 561 - 561
  • [5] Plasma-derived versus recombinant factor VIII concentrates for the treatment of haemophilia A: plasma-derived is better
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2010, 8 (04) : 288 - 291
  • [6] The increased demand for plasma-derived factor VIII in Italy
    Arcieri, Romano
    Calizzani, Gabriele
    Candura, Fabio
    Mannucci, Pier Mannuccio
    BLOOD TRANSFUSION, 2017, 15 (03) : 279 - 280
  • [7] Relationships between factor VIII:Ag and factor VIII in recombinant and plasma-derived factor VIII concentrates
    Lin, Y
    Yang, X
    Chevrier, MC
    Craven, S
    Barrowcliffe, TW
    Lemieux, R
    Ofosu, FA
    HAEMOPHILIA, 2004, 10 (05) : 459 - 469
  • [8] INHIBITOR QUESTIONS - PLASMA-DERIVED FACTOR-VIII AND RECOMBINANT FACTOR-VIII
    BRAY, G
    ANNALS OF HEMATOLOGY, 1994, 68 : S29 - S34
  • [9] A Plasma-Derived Von Willebrand Factor/Factor VIII Concentrate (Wilate)
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2010, 52 (1340): : 45 - 46
  • [10] Factor VIII safety: plasma-derived versus recombinant products
    Gringeri, Alessandro
    BLOOD TRANSFUSION, 2011, 9 (04) : 366 - 370
12345